Orion Porfolio Solutions LLC reduced its position in Cigna Group (NYSE:CI – Free Report) by 14.4% in the 3rd quarter, Holdings Channel reports. The firm owned 38,964 shares of the health services provider’s stock after selling 6,558 shares during the quarter. Orion Porfolio Solutions LLC’s holdings in Cigna Group were worth $11,231,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after purchasing an additional 4,738 shares in the last quarter. Maj Invest Holding A S increased its holdings in shares of Cigna Group by 2.4% in the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after purchasing an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC lifted its position in Cigna Group by 1,016.8% during the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after buying an additional 7,748 shares in the last quarter. National Pension Service boosted its stake in Cigna Group by 3.2% during the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after buying an additional 21,203 shares during the last quarter. Finally, SCS Capital Management LLC grew its holdings in Cigna Group by 39.1% in the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after buying an additional 8,609 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Key Cigna Group News
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Cigna received an independent credit-rating vote of confidence: AM Best affirmed A (Excellent) FSR and “a+” long‑term issuer credit ratings for Cigna’s core life/health subsidiaries — supports financial stability and capital strength. AM Best affirms ratings
- Positive Sentiment: Cigna formally named President & COO Brian Evanko as its next CEO (effective July 1) and said Cordani will move to executive chair; management also reaffirmed 2026 financial outlook — the internal succession and guidance reaffirmation reduce execution/guidance risk versus an outsider pick. Cigna appoints Brian Evanko
- Neutral Sentiment: Cigna executives appeared at the TD Cowen healthcare conference this week — useful for incremental detail and Q&A but not a market-moving catalyst on its own. TD Cowen presentation notice
- Neutral Sentiment: Broader health-care weakness intraday pressured peers as the NYSE Health Care Index slipped — sector moves amplify company-specific headlines but are not unique to CI. Sector update
- Negative Sentiment: Market reaction to the CEO transition has been negative in the near term — investors appear concerned about leadership change and potential strategic shifts at Evernorth/PBM despite the internal appointment. Seeking Alpha on leadership transition
- Negative Sentiment: Piper Sandler (per recent coverage) issued a cautious note on near‑term outlook for CI, which can weigh on sentiment even if other analysts remain constructive. Piper Sandler pessimistic forecast
- Negative Sentiment: Insider selling was reported (director-level sale of ~1.7k shares) — small in isolation but often cited by traders as a short-term negative signal. Insider trade filing
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on CI
Cigna Group Stock Performance
Shares of CI stock opened at $281.21 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a market cap of $74.11 billion, a P/E ratio of 12.68, a P/E/G ratio of 0.99 and a beta of 0.27. The firm’s 50 day moving average price is $280.80 and its 200-day moving average price is $284.43. Cigna Group has a one year low of $239.51 and a one year high of $350.00.
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the previous year, the company earned $6.64 earnings per share. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts predict that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 27.23%.
Insider Activity
In other news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.70% of the company’s stock.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- [How To] Invest Pre-IPO In SpaceX With $100!
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
